Since myocardium is rich in glyceraldehyde phosphate dehydrogenase (GAPDH), we performed 115 serum GAPDH determinations in 63 patients with acute myocardial infarction and 54 hospitalized control subjects in order to evaluate serum GAPDH as an index of myocardial necrosis. The normal range (mean -c-2 SD) for serum GAPDH was found to be 16 a 12 milli International Units, (mIU)/ml. In 41 petients with infarction studied within 24 hours of the onset of symptoms, mean serum GAPDH activity increased to 53 mIU @ <.01). Serum GAPDH activity was within the normal range (ie < 28 mIU/ml) in only three patients (7 percent) from whom samples could be obtained within 24 hours following onset of chest pain. In these and additional patients studied serially following infarction, mean serum GAPDH remained elevated only transiently. In 16 of 63 patients with acute myocardial infarction serum GAPDH increased before serum creatine phosphokinase (CPK) increased, and in 18 of 63 before glulamic-oxaloacetic transaminase (SGOT) rose. In addition, serum GAPDH elevations accompanied electrocardiographic and clinical evidence of extension of myocardial i n f k t i o n in six of six while conventionally measured enzyme values declined or did not change. Thus, determination of serum GAPDH activity appears to be a sensitive and potentially useful adjunct in the prompt recognition of the occurrence and extension of myocardial infarction in man.
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lthough myocardium of several species exhibits A marked glyceraldehyde phosphate dehydrogenase (GAPDH) activity,l changes in GAPDH activity in serum following myocardial injury have not been characterized, and elevated serum GAPDH has not been utilized as an index of myocardial necrosis in man. GAPDH activity in tissue extracts and serum can be assayed rapidly -.
and conveniently with the use of a spectrophotometric procedure readily adaptable for use in the clinical laboratory. Accordingly, the present study was designed to explore the possible value of serial serum GAPDH determinations in patients with acute n~yocardial infarction particul&ly with re-'From the Department of hledicine, School of Medicine, University of California, San Diego ( La Jolla ) . 
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Abbreviations: ASHD: arteriosclerotic heart diaeaae with congestive failure and/or angina pectoria but without acute myocardial infarction. COPD: chronic obetructive pulmonary dieeaae. IHSS: idiopathic hypertrophic subaortic stenoh. RHD: rheumatic heart diseaae.
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The experimental group consisted of 63 patients with acute myocardial infarction fulfilling at least two of the following three criteria: ( 1 ) typical history and physical findings, ( 2 ) characteristic serial changes in conventionally available serum enzyme determinations including creatine phosphokinase ( CPK ) and glutamic-oxaloacetic transaminase ( SCOT ), and ( 3 ) electrocardiograms satisfying criteria diagnostic of transmural infarction. This group consisted of 40 men (63.5 percent) and 23 women with a mean age of 62 years ( Table  2 ) . For purposes of analysis results in the experimental group were compared to those in samples from the hospitalized patient control group. Mean age, age distribution, and sex distribution were similar in experimental and control groups.
Chemical Procedures
Reagents were formulated in doubly glass distilled water. Triethanolamine hydrochloride, sodium ethylenediaminetetraacetic acid ( EDTA ), reduced nicotinamide adenine dinucleotide ( NADH ), dipotassium adenosine triphosphate ( ATP ), trihydroxymethylaminornethane ( TRIS ), bovine serum albumin, mercaptoethanol, sodium pyruvate, and beef heart LDH were obtained from Sigma Chemical Company. Sodium lactate, 3-phosphoglycerate kinase, rabbit muscle GAPDH, nitroblue tetrazolium, phenazine methosulfate, glycine and 3-phosphoglycerate (sodium salt) were obtained from Calbiochem. Bromophenol blue, sucrose, ammonium persulfate, acrylamide, bisacrylamide, and N,N,N',N1-tetamethylene diamine ( TEMED) were obtained from Canalco.
Serum GAPDH activity was determined spectrophotometrically by a modification of Schmidt's procedure. The change in optical density at 340 mp corrected for base line activity was used to calculate results expressed as mIU/ml serum. ' LDH isoenzymes were determined by disc gel electro~horesis according to the method of Dietz and Lubranos with the use of a Canalco electrophoresis chamber, a Beckman duostat power supply, and photovolt microdensitometer, recorder, and integrator. Gels were run at a constant current of 2.5 mA/tube for 90 minutes. Total LDH activity was determined as previously describql.4
Serum GAPDH Activity in Control Subjects
The mean +-2 standard deviations of GAPDH values in samples from subjects in the control group was found t o b e 16 + 12 mIU/ml. Accordingly, the normal range for serum GAPDH activity was defined as 4 to 28 mIU/ml. The mean and standard deviation obtained in samples from 31 fasting healthy ambulatory volunteers were slightly lower (11 + 8mIUlml) perhaps because of age related differences. In order to avoid apparent differences in GAPDH activity due to age, sex, or other independent variablks in comparing control subjects 'One mlU is the amount of enzyme catalyzing oxidation of 1 mpmole of NADH/min. 
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Serum GAPDH Activity in Patients with Acute Myoardial Znfarctiun
Results obtained in 115 samples from 63 patients with acute myocardial infarction are tabulated in Table 2 . In 41 patients studied within 24 hours after the onset of acute myocardial infarction, serum GAPDH activity averaged 53 mIU/ml, and values ranged from 10 to 115 mIU/rnl. Additional samples were obtained from most of these patients over the next one to three days for serial GAPDH determinations. Twenty-four additional patients entered the study more than 24 hours after the onset of symptoms. The composite time course of changes in serum GAPDH activity following the onset of symptoms in patients with myocardial infarction is illustrated in Figure 1 . Results in this figure include all values from all patients studied, grouped according to the time the sample was obtained after the onset of the patient's symptoms. As can be seen, mean GAPDH activity was maximally increased within the first 12 hours. Within 12 to 24 hours following the onset of symptoms, mean GAPDH activity began to return toward normal. In 16 instances, definite elevation of serum GAPDH activity (exceeding two standard deviations from the normal mean) occurred 6 to 24 hours before serum CPK activity increased, and in 18 instances it occurred 4 to 24 hours before SGOT increased. The mean of serum GAPDH activity in all samples obtained within each of the &st four days following myocardial infarction was significantly greater than the mean serum GAPDH activity in all samples from hospitalized control patients ( p < .01). However, in general, in patients with myocardial infarction, serum GAPDH rose promptly, peaked early, and declined rapidly after onset of symptoms. This is reflected in the time course of change in mean serum GAPDH in all samples from such patients grouped according to the time samples were obtained after onset of each patient's symptoms.
Changes in Serum GAPDH Activity Related to Extension of Infarction
In six instances, patients recovering from an initial infarction manifested electrocardiographic and clinical evidence indicative of extension of myocardial infarction. In each case marked transient elevations of serum GAPDH activity occurred within hours in the face of unchanged or declining conventional serum enzyme values during the ensuing 24 hours. An example is illustrated in Figure  2 .
Serum LDH Zsoenzymes in Control Subjects and Patients with Acute Myoardial Infarction
Based on previous studies the ratio of LDH isoenzyme 1 (LDH1) to LDH isoenzyme 2 (LDH2 ) was chosen as an independent indicator of myocardial damage.5~6 In 33 control subjects (19 ambulatory normal adults and 14 hospitalized control subjects) the normal range for this ratio (mean & 2 standard deviations) was found to be 0.70 + 0.18. Because the LDHIILDH~ ratio may be increased in women of childbearing age, they were excluded from the control group.7 In 54 patients with acute myocardial infarction, the mean LDHl/LDH2 ratio was 1.07, with values ranging from 0.66 to 1.45 ( Fig 3) . Increased LDH1 /LDH2 ratios were frequently observed in samples with normal total LDH activity. However, o?ce the ratio became abnormal in any given patient, it persisted with little variation for one to three weeks. In most hospitalized patients with GAPDH elevations not associated with acute myocardial infarction, the LDHl/LDH2 ratio was normal or low, probably because of the contribution of LDH components with slower electrophoretic mobility from liver and skeletal muscle.
DAYS AFTER ONSET OF SYMPTOMS
Serum GAPDH in Patients with Angina Pectoris and1 or Congestive Heart Failure ;
Serum GAPDH activity was measured within 2A hours in 17 patients with angina pectoris admitted to the hospital because of chest pain but failing to exhibit diagnostic electrocardiographic changes or conventional serum enzyme changes indicative of myocardial infarction. Serum GAPDH activity remained within the normal range in all patients. In 7 of 13 patients with severe congestive heart failure, manifested by abnormally elevated central venous pressure, pulmonary edema, and hepatomegally, serum GAPDH activity was increased ranging from 30 to 40 mIU/ml. However, these elevations were persistent and associated with low LDH1/LDH2 ratios and hence readily distinguishable from the transient elevations seen in patients with acute myocardial infarction. Serum 
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Other Disorders Associated with Elevated
GAPDH Activity
Serum GAPDH activity was elevated in 17 hospitalized patients not initially selected for inclusion in the control group but with disorders anticipated to be associated with marked alterations in activities of many serum enzymes. The diagnoses of patients in this group and their serum GAPDH values are shown in Table 3 . In these patients abnormal serum GAPDH values were persistent for at least several days and generally associated with normal or decreased LDH1/LDH2 ratios. Thus, they too were readily distinguishable from patients with elevations of GAPDH following occurrence of acute myocardial infarction.
Although the value of determinations of SGOT, CPK, and LDH in the diagnosis of acute myocardial infarction is well established, the sensitivity and specificity of these procedures exhibit unavoidable shortcomings particularly with respect to early diagnosis of infarction and to detection of extension of myocardial necrosis. SGOT activity usually increases early and reaches a peak within 24 to 48 hours, but in some patients elevations may not occur until 36 hours after the onset of symptoms.8 Elevated serum CPK activity may occur in conditions other than acute myocardial infarction, including pulmonary embolism.9 Serum LDH activity often rises relatively late following acute myocardial infarction and frequently remains elevated for 8 to 14 days."n view of this delayed and persistent elevation, additional myocardial damage during the recovery phase following acute infarction is often not reflected by changes in total serum LDH activity or the LDH, /LDH2 ratio.
In preliminary experiments we found that guinea pig, rat, dog, cat, and human myocardium are rich in GAPDH activity; this confirmed previous reports,' and we observed no increase in serum GAPDH activity following experimental pulmonary embolism in the dog despite increases in serum CPK.9 Accordingly, we performed the present investigation in order to define the usefulness and limitations of determination of activity of serum GAPDH in detecting acute myocardial infarction in man.
Results obtained indicate that assay of serum GAPDH activity provides a sensitive means of detecting acute and recurrent myocardial injury. In samples obtained within 24 hours after acute myocardial infarction, serum GAPDH activity rose markedly to an average of 3.3 times control values. When compared with SGOT, CPK, and LDH, serum GAPDH frequently rose earlier and more rapidly following acute myocardial necrosis. In 16 patients serum GAPDH activity was significantly increased 6 to 24 hours before serum CPK activity rose. This is not entirely unexpected since peak elevation of serum CPK activity occurs within 18 to 24 hours following acute myocardial infarction, while peak serum GAPDH activity generally occurs within the first 12 hours. In 18 patients serum GAPDH activity increased 4 to 24 hours prior to SGOT elevation. On the other hand, serum GAPDH activity was less than 28 mIU/rnl, ie a value within the mean + 2 standard deviations of the control group, in samples from only 3 of 41 patients studied within 24 hours of acute myocardial infarction. Thus, serum GAPDH elevation is a sensitive index of acute myocardial infarction, particularly early after the onset of symptoms. Although the mean serum GAPDH activity in samples obtained within 24 hours differed significantly from the mean of the control values, some overlap between the two groups occurred. This is not surprising since peak GAPDH activity occurs so early. In only one out of 29 cases did the value in a sample obtained from a patient within 18 hours following onset of symptoms fall within the entire range of values in samples from control hospitalized subjects.
Since serum GAPDH activity rose promptly and only transiently following myocardial injury, it seemed likely that assay of this enzyme might be useful in the early detection of extension of acute infarction. As shown in Figure 2 in serum GAPDH activity closely followed the recurrence of chest pain accompanied by reappearance of ST segment elevation in the face of declining or insignificantly changed values for serum SGOT, CPK, and total LDH activity. The rate of change of activity of any serum enzyme depends on several factors including: (1) prevailing level of activity; ( 2 ) rate of degradation; ( 3 ) rate of excretion; ( 4 ) rate of removal from the circulation by the reticuloendothelial system.11 "Spikes" in GAPDH activity associated with extension of infarction or recurrence may be more prominent than changes in conventionally measured enzymes because prevailing serum GAPDH activity is ordinarily low and return to baseline activity is quite prompt following elevations associated with myocardial infarction.
The interpretation of elevated serum GAPDH activity may be facilitated in equivocal cases, particularly in patients with other disorders likely to be associated with elevated serum enzyme activities, by consideration of the LDH1/LDH2 isoenzyrne ratio. Thus, although serum GAPDH activity increases in some patients with congestive heart failure, presumably because of hepatic congestion, and in patients with liver disease of a variety of etiologies (Table 3 ) , such abnormalities are associated with low LDH1 / LDH2 isoenzyme ratios,l2.13 probably reflecting release of predominantly slower migrating LDH isoenzyme components from liver. However, when brisk GAPDH elevations occur in association with the increased LDHI /LDH2 ratio typically seen following myocardial infarction, extension of myocardial damage is likely.
Serum GAPDH activity increases characteristically and consistently following acute myocardial infarction, often before conventionally measured serum enzyme activities are elevated. Although increased serum GAPDH may be due to hepatic, musculoskeletal, pulmonary or neoplastic disease, such increases are often associated with normal or low LDHl/LDH2 ratios. On the other hand, although the LDHl/LDH2 ratio once elevated may be persistently abnormal for a considerable period of time following acute myocardial infarction, the combination of increased serum GAPDH activity and elevated LDHI /LDH2 ratio in the patient with chest pain strongly suggests acute myocardial infarction or extension of necrosis. Thus, determination of serum GAPDH activity appears to be a potentially useful adjunct in the early detection of acute myocardial infarction.
